BioSpace News Archive

Pharm Country

Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory DLBCL, PMBCL and FL3B

Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory DLBCL, PMBCL and FL3B.

January 28, 2022
·
17 min read
Genetown

AVROBIO to Present at Cowen’s 2nd Annual Genetic Medicines Summit

AVROBIO, Inc. announced Azadeh Golipour, Ph.D., chief technology officer at AVROBIO, will present virtually at Cowen’s 2nd Annual Genetic Medicines Summit at 2:00 p.m. ET on Thursday, Feb. 3, 2022.

January 28, 2022
·
5 min read
Alterity Therapeutics Announces Publication Demonstrating that ATH434 is Neuroprotective in Animal Model of Parkinsonian Disorder in the Journal of Parkinson’s Disease

Alterity Therapeutics today announced that data in an animal model of Multiple System Atrophy (MSA) were published in the Journal of Parkinson’s Disease. MSA is a devastating neurodegenerative disorder without approved therapy.

January 28, 2022
·
7 min read
Much Awaited, Much Needed: TRANSFORM II Randomized Controlled Trial, by Fondazione RIC, gets rolling

FONDAZIONE Ricerca e Innovazione Cardiovascolare, Milano , focused on cardiovascular research, reports the first patient enrolment of the TRANSFORM II.

January 28, 2022
·
4 min read
Biotech Bay

World-Renowned Heart Failure Physicians To Feature Innovative Heart Failure Therapies at Technology and Heart Failure Therapeutics, February 1-2, 2022

Innovative therapeutic approaches for the left ventricle may slow progression or reverse congestive heart failure.

January 28, 2022
·
3 min read
BioMidwest

Nutriband Issued Full US Patent for Its Aversa(TM) Abuse Deterrent Transdermal Platform by United States Patent and Trademark Office

Nutriband Inc. announced the receipt of an Issue Notification from the United States Patent and Trademark Office for its United States patent entitled, “Abuse and Misuse Deterrent Transdermal System,” that protects its AVERSA™ transdermal abuse deterrent technology.

January 28, 2022
·
4 min read
Business

Monrol Signing Agreement to License its GMP Grade Lu-177 n.c.a Production Technology to Curium

Eczacıbaşı-Monrol Nuclear Products Co. (Monrol) has today announced it has signed an agreement with Curium Netherlands B.V (Curium) to license its GMP grade medical radioisotope, no-carrier-added 177 Lu (n.c.a. 177 Lu) cutting-edge production technology LuMagic®.

January 28, 2022
·
4 min read
Press Releases

Maravai LifeSciences Acquires MyChem, a Leader in Proprietary Ultra-Pure Nucleotides

MyChem’s nucleotide synthesis methods are highly complementary to Maravai’s TriLink mRNA technologies Increases capabilities serving the high-growth cell and gene therapy market.

January 28, 2022
·
5 min read
Business

HTG Appoints Biopharmaceutical Industry Veteran Christopher Kiritsy to its Board of Directors

HTG Molecular Diagnostics, Inc. announced it has appointed biopharmaceutical industry veteran Christopher Kiritsy to its Board of Directors.

January 28, 2022
·
4 min read
Business

Advaxis Prices Offering of $5,000,000 of Convertible Redeemable Preferred Stock Through a Private Placement

Advaxis, Inc today announced that the Company entered into an agreement with certain institutional investors for the private placement of 1,000,000 shares of Series D convertible redeemable preferred stock.

January 28, 2022
·
5 min read